Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-κB and AP-1-dependent MMP-9 expression

Molecules and Cells

Volumn 29, Issue 2, 2010, Pages 209-215

  Park, Jung Hyun ^b   Jeong, Yun Jeong ^a   Park, Kwan Kyu ^a   Cho, Hyun Ji ^a   Chung, Il Kyung ^a   Min, Kwan Sik ^c   Kim, Mihyun ^d   Lee, Kwang Gill ^e   Yeo, Joo Hong ^e   Park, Kwang Kyun ^f   Chang, Young Chae ^a  

^a Catholic University of Daegu   (South Korea)

^b Eulji University   (South Korea)

^c Hankyong National University   (South Korea)

^d Inje University   (South Korea)

^e National Institute of Animal Science   (South Korea)

^f Yonsei University College of Dentistry   (South Korea)

Author keywords

Bee venom; Caki 1 renal carcinoma cells; Invasion; Melittin; MMP 9

Indexed keywords

APAMIN; BEE VENOM; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELITTIN; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 12 ACETATE 13 MYRISTATE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KIDNEY CANCER; PROMOTER REGION; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

APAMIN; CELL LINE, TUMOR; CELL MOVEMENT; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MELITTEN; NEOPLASM INVASIVENESS; NF-KAPPA B; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1;

APOIDEA;

EID: 77949425064     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-010-0028-9     Document Type: Article

References (43)

1. Benelli, R., Adatia, R., Ensoli, B., Stetler-Stevenson, W.G., Santi, L., and Albini, A. (1994). Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Oncol. Res. 6, 251-257.
2. Chae, Y.M., Park, K.K., Magae, J., Lee, I.S., Kim, C.H., Kim, H.C., Hong, S., Lee, J.G., Choi, I.J., Chang, Y.C., et al. (2004). Sp1-decoy oligodeoxynucleotide inhibits high glucose-induced mesangial cell proliferation. Biochem. Biophys. Res. Commun. 319, 550-555.
3. Chambers, A.F., and Matrisian, L.M., (1997). Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 260-270.
4. Cho, B.J., Im, E.K., Kwon, J.H., Lee, K.H., Shin, H.J., Oh, J., Kang, S.M., Chung, J.H., and Jang, Y. (2005). Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells. Mol. Cells 20, 429-434.
5. Cho, H.J., Kang, J.H., Kwak, J.Y., Lee, T.S., Lee, I.S., Park, N.G., Nakajima, H., Magae, J., and Chang, Y.C. (2007). Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis 28, 1104-1110.
6. Chu, S.T., Cheng, H.H., Huang, C.J., Chang, H.C., Chi, C.C., Su, H.H., Hsu, S.S., Wang, J.L., Chen, I.S., Jan, C.R., et al. (2007). Phospholipase A2-independent Ca2+ entry and subsequent apoptosis induced by melittin in human MG63 osteosarcoma cells. Life Sci. 80, 364-369.
7. De Clerck, Y.A., Darville, M.I., Eeckhout, Y., and Rousseau, G.G. (1994). Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene 139, 185-191.
8. Dempsey, C.E. (1990). The actions of melittin on membranes. Biochim. Biophys. Acta 1031, 143-161.
9. Eberhardt, W., Huwiler, A., Beck, K.F., Walpen, S., and Pfeilschifter, J. (2000). Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J. Immunol. 165, 5788-5797.
10. Gevod, V.S., and Birdi, K.S. (1984). Melittin and the 8-26 fragment. Differences in ionophoric properties as measured by monolayer method. Biophys. J. 45, 1079-1083.
11. Gum, R., Lengyel, E., Juarez, J., Chen, J.H., Sato, H., Seiki, M., and Boyd, D. (1996). Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem. 271, 10672-10680.
12. Gum, R., Wang, H., Lengyel, E., Juarez, J., and Boyd, D. (1997). Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14, 1481-1493.
13. Hider, R.C. (1988). Honeybee venom: a rich source of pharmacologically active peptides. Endeavour 12, 60-65.
14. Hong, S., Park, K.K., Magae, J., Ando, K., Lee, T.S., Kwon, T.K., Kwak, J.Y., Kim, C.H., and Chang, Y.C. (2005). Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. J. Biol. Chem. 280, 25202-25209.
15. Jang, M.H., Shin, M.C., Lim, S., Han, S.M., Park, H.J., Shin, I., Lee, J.S., Kim, K.A., Kim, E.H., and Kim, C.J. (2003). Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. J. Pharmacol. Sci. 91, 95-104.
16. Kohler, M., Hirschberg, B., Bond, C.T., Kinzie, J.M., Marrion, N.V., Maylie, J., and Adelman, J.P. (1996). Small-conductance, calcium-activated potassium channels from mammalian brain. Science 273, 1709-1714.
17. Kwon, Y.B., Lee, J.D., Lee, H.J., Han, H.J., Mar, W.C., Kang, S.K., Beitz, A.J., and Lee, J.H. (2001). Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain 90, 271-280.
18. Kwon, Y.B., Lee, H.J., Han, H.J., Mar, W.C., Kang, S.K., Yoon, O.B., Beitz, A.J., and Lee, J.H. (2002). The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci. 71, 191-204.
19. Lakka, S.S., Gondi, C.S., Yanamandra, N., Olivero, W.C., Dinh, D.H., Gujrati, M., and Rao, J.S. (2004). Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23, 4681-4689.
20. Lee, S.J., Sakurai, H., Oshima, K., Kim, S.H., and Saiki, I. (2003). Anti-metastatic and anti-angiogenic activities of a new matrix metalloproteinase inhibitor, TN-6b. Eur. J. Cancer 39, 1632-1641.
21. Lee, S.O., Jeong, Y.J., Im, H.G., Kim, C.H., Chang, Y.C., and Lee, I.S. (2007). Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Biochem. Biophys. Res. Commun. 354, 165-171.
22. Lein, M., Jung, K., Laube, C., Hubner, T., Winkelmann, B., Stephan, C., Hauptmann, S., Rudolph, B., Schnorr, D., and Loening, S.A. (2000). Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma. Int. J. Cancer 85, 801-804.
23. Lin, C.W., Hou, W.C., Shen, S.C., Juan, S.H., Ko, C.H., Wang, L.M., and Chen, Y.C. (2008). Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 29, 1807-1815.
24. Moon, D.O., Park, S.Y., Heo, M.S., Kim, K.C., Park, C., Ko, W.S., Choi, Y.H., and Kim, G.Y. (2006). Key regulators in bee venominduced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt. Int. Immunopharmacol. 6, 1796-1807.
25. Moon, D.O., Park, S.Y., Choi, Y.H., Kim, N.D., Lee, C., and Kim, G.Y. (2008). Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells. Toxicon 51, 112-120.
26. Nabeshima, K., Inoue, T., Shimao, Y., and Sameshima, T. (2002). Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol. Int. 52, 255-264.
27. Nah, S.S., Ha, E., Lee, H.J., and Chung, J.H. (2007). Inhibitory effects of melittin on the production of lipopolysaccharideinduced matrix metalloproteinase 3 in human osteoarthritic chondrocytes. Toxicon 49, 881-885.
28. Nakshatri, H., Bhat-Nakshatri, P., Martin, D.A., Goulet, Jr. R.J., and Sledge, Jr. G.W. (1997). Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17, 3629-3639.
29. Orsolic, N., Sver, L., Verstovsek, S., Terzic, S., and Basic, I. (2003). Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom. Toxicon 41, 861-870.
30. Park, D., Shim, E., Kim, Y., Kim, Y.M., Lee, H., Choe, J., Kang, D., Lee, YS., and Jeoung, D. (2008). C-FLIP promotes the motility of cancer cells by activating FAK and ERK, and increasing MMP-9 expression. Mol. Cells 25, 184-195.
31. Ray, J.M., and Stetler-Stevenson, W.G. (1994). The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J. 7, 2062-2072.
32. Sato, H., and Seiki, M. (1993). Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8, 395-405.
33. Shishodia, S., Majumdar, S., Banerjee, S., and Aggarwal, B.B. (2003). Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of Ikappa-Balpha kinase and p65 phosphorylation: correlation with downregulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 63, 4375-4383.
34. Simon, C., Goepfert, H., and Boyd, D. (1998). Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMAinduced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res. 58, 1135-1139.
35. Son, Y.O., Lee, K.Y., Choi, K.C., Chung, Y., Kim, J.G., Jeon, Y.M., Jang, Y.S., and Lee, J.C. (2004). Inhibitory effects of glycoprotein-120 (G-120) from Ulmus davidiana Nakai on cell growth and activation of matrix metalloproteinases. Mol. Cells 18, 163-170.
36. Son, D.J., Ha, S.J., Song, H.S., Lim, Y., Yun, Y.P., Lee, J.W., Moon, D.C., Park, Y.H., Park, B.S., Hong, J.T., et al. (2006). Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor-kappaB and Akt activation and enhancement of apoptotic protein expression. J. Pharmacol. Exp. Ther. 317, 627-634.
37. Son, D.J., Lee, J.W., Lee, Y.H., Song, H.S., Lee, C.K., and Hong, J.T. (2007). Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol. Ther. 115, 246-270.
38. Stetler-Stevenson, W.G., Brown, P.D., Onisto, M., Levy, A.T., and Liotta, L.A. (1990). Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 265, 13933-13938.
39. Stetler-Stevenson, W.G., Hewitt, R., and Corcoran, M. (1996). Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin. Cancer Biol. 7, 147-154.
40. Wang, C., Chen, T., Zhang, N., Yang, M., Li, B., Lü, X., Cao, X., and Ling, C. (2009). Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IkappaBalpha kinase-NFkappaB. J. Biol. Chem. 284, 3804-3813.
41. Woo, M.S., Jung, S.H., Kim, S.Y., Hyun, J.W., Ko, K.H., Kim, W.K., and Kim, H.S. (2005). Curcumin suppresses phorbol esterinduced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem. Biophys. Res. 335, 1017-1025.
42. Zucker, S., Lysik, R.M., Zarrabi, M.H., and Moll, U. (1993). M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res. 53, 140-146.
43. Zucker, S., Cao, J., and Chen, W.T. (2000). Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 19, 6642-6650.